Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9817
Gene Symbol: KEAP1
KEAP1
0.010 GeneticVariation disease BEFREE Identification of novel Nrf2/Keap1 pathway mutations in pediatric acute lymphoblastic leukemia. 31661353 2020
Entrez Id: 5340
Gene Symbol: PLG
PLG
0.010 Biomarker disease BEFREE Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia. 31556233 2020
Entrez Id: 7295
Gene Symbol: TXN
TXN
0.010 Biomarker disease BEFREE Here, we show that the Trx inhibitor PX-12 reduced cell viability and induced cell death in a dose- and time-dependent manner in different ALL cell lines. 31352431 2020
Entrez Id: 255738
Gene Symbol: PCSK9
PCSK9
0.010 AlteredExpression disease BEFREE In the present study, PCSK9 expression was measured in acute lymphoblastic leukemia (ALL) patients and was found to be significantly induced. 31812013 2020
Entrez Id: 2324
Gene Symbol: FLT4
FLT4
0.010 Biomarker disease BEFREE The obtained PCL-ss-Ara@Sgc8-BSA exhibited good GSH-responsive drug release behavior, obvious targetability and sufficient antitumor effect to acute lymphoblastic leukemia (ALL) cells (CCRF-CEM). 31769777 2019
Entrez Id: 645682
Gene Symbol: POU5F1P4
POU5F1P4
0.010 Biomarker disease BEFREE Recombinant plasmid pcDNA3.1-OCT4 was constructed and transferred into ALL MSCs by liposome transfection. 31159871 2019
Entrez Id: 100126315
Gene Symbol: MIR665
MIR665
0.010 AlteredExpression disease BEFREE Moreover, low EXT1 and high miR-665 expression levels in adult ALL bone marrow tissues are correlated with poor patient survival. 31465316 2019
Entrez Id: 1271
Gene Symbol: CNTFR
CNTFR
0.010 Biomarker disease BEFREE The expressions of miR-146a and ciliary neurotrophic factor receptor (CNTFR) were detected by quantitative real-time polymerase chain reaction (qRT-PCR) in ALL and AML pediatric patients, as well as ALL (Jurkat) and AML (HL-60) cells. 31538427 2019
Entrez Id: 472
Gene Symbol: ATM
ATM
0.010 Biomarker disease BEFREE Together, these results demonstrated that ATM-dependent NF-κB activation mediated the cytokines induction by chemotherapy and ALL resistance to chemotherapeutics. 30940905 2019
Entrez Id: 822
Gene Symbol: CAPG
CAPG
0.010 GeneticVariation disease BEFREE A total of 96 children with ALL undergoing therapy with MCP-841 protocol were screened for all the ten exons of TPMT, exon 2, exon 3 and intron 2 of ITPA using bidirectional sequencing. 30806759 2019
Entrez Id: 26234
Gene Symbol: FBXL5
FBXL5
0.010 Biomarker disease BEFREE Furthermore, genes including ALPK1, ZNF695, ACTN4, CALR, and FBXL5 might be novel prognostic genes for relapsed ALL. 31030124 2019
Entrez Id: 55364
Gene Symbol: IMPACT
IMPACT
0.010 Biomarker disease BEFREE The IMPACT Cohort is an Ontario population-based cohort that captured demographic, disease and treatment (treatment protocol, chemotherapy doses) data for all 15-21 year olds diagnosed with ALL 1992-2011. 30912628 2019
Entrez Id: 5460
Gene Symbol: POU5F1
POU5F1
0.010 Biomarker disease BEFREE Recombinant plasmid pcDNA3.1-OCT4 was constructed and transferred into ALL MSCs by liposome transfection. 31159871 2019
Entrez Id: 100313824
Gene Symbol: MIR663B
MIR663B
0.010 Biomarker disease BEFREE Expression and Role of MicroRNA-663b in Childhood Acute Lymphocytic Leukemia and its Mechanism. 31844676 2019
Entrez Id: 4854
Gene Symbol: NOTCH3
NOTCH3
0.010 Biomarker disease BEFREE Deregulated Notch, either Notch1 or Notch3, and CXCR4 receptor signaling are involved in ALL disease development and progression. 31346528 2019
Entrez Id: 84868
Gene Symbol: HAVCR2
HAVCR2
0.010 Biomarker disease BEFREE CD4+PD1+TIM3+ T cells were independent predictors of poor outcome in our multivariate risk model, suggesting that PD1 might serve as an attractive immuno-oncological target in B-ALL. 30635636 2019
Entrez Id: 57116
Gene Symbol: ZNF695
ZNF695
0.010 Biomarker disease BEFREE ALPK1, ACTN4, CALR, and ZNF695 were identified as the potential prognosis risk factors in adult ALL. 28485154 2019
Entrez Id: 1131
Gene Symbol: CHRM3
CHRM3
0.010 AlteredExpression disease BEFREE The present study aimed to determine the expression of M3-mAChR and α7-nAChR in the bone marrow or peripheral blood of 51 patients with leukemia, including acute myeloid leukemia (AML; n=33), acute lymphoblastic leukemia (ALL; n=13), and chronic myeloid leukemia (CML; n=5). 30655906 2019
Entrez Id: 1236
Gene Symbol: CCR7
CCR7
0.010 Biomarker disease BEFREE In addition, the chemokine receptor CCR7 controls CLL cell homing to LNs, and CXCR4, CCR7, and CXCR3 contribute to ALL cell migration across endothelia and the blood brain barrier. 30787933 2019
Entrez Id: 8878
Gene Symbol: SQSTM1
SQSTM1
0.010 Biomarker disease BEFREE Another, less frequent fusion protein involving the C terminus of NUP214 results in the sequestosome-1 (SQSTM1)-NUP214 chimera, which was detected in ALL. 30669574 2019
Entrez Id: 642559
Gene Symbol: POU5F1P3
POU5F1P3
0.010 Biomarker disease BEFREE Recombinant plasmid pcDNA3.1-OCT4 was constructed and transferred into ALL MSCs by liposome transfection. 31159871 2019
Entrez Id: 283131
Gene Symbol: NEAT1
NEAT1
0.010 Biomarker disease BEFREE Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia. 30639603 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.010 AlteredExpression disease BEFREE Fibrinogen, von Willebrand factor antigen (VWF:Ag), total protein, and albumin levels as well as antithrombin (AT) and L-asparaginase activities were measured in 97 children with ALL treated for prolonged period of time with L-asparaginase. 30938058 2019
Entrez Id: 10135
Gene Symbol: NAMPT
NAMPT
0.010 Biomarker disease BEFREE Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia. 31848452 2019
Entrez Id: 644943
Gene Symbol: RASSF10
RASSF10
0.010 Biomarker disease BEFREE Due to the high applicability, the non-invasiveness, and promising prospect of longitudinal assessment, the DNA methylation status of the RASSF6 and RASSF10 genes could be potential biomarkers for the assessment of residual disease in PB of patients with ALL. 31486880 2019